Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivoglitazone in type 2 diabetes mellitus
NCT00575471Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rivoglitazone in type 2 diabetes mellitus (T2DM), sponsored by Daiichi Sankyo Co., Ltd.. Started Jul 2007; status: completed.
02
Drugs
rivoglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00575471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00575471.